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Bioengineered nanomaterials have inspired revolutionary
imaging and drug delivery methods whose clinical appli-
cation in cancer research has resulted in powerful medi-
cal devices for early diagnosis, treatment, and prevention
of cancer. Recent advances in super imaging agents have
resulted in improved resolution and sensitivity. For instance,
fluorescent quantum dots with wavelength-tunable emis-
sions, plasmon-resonant gold nanostructures with shape-
controlled near-infrared absorptions, and MRI-active iron
oxide nanoparticles are well-established molecular imaging
probes for noninvasive cancer imaging. Nanomaterials are
also considered to be themost effective vectors that can break
through transport biobarriers and deliver a constant dose of
multiple therapeutic agents to tumors and intracellular endo-
cytic compartments for cancer gene therapy, immunotherapy,
or chemotherapy. Furthermore, nanowire- or nanotube-
based electronic devices demonstrate extraordinary sensitiv-
ity capable of detection at the single molecule or protein
level. It is anticipated that developing nanotechnology-driven
imaging, sensing, and therapeutic systems will dramatically
advance cancer research and clinical treatments.
We organized this special issue aiming to visualize the
current progress in the emerging multidisciplinary field
of cancer nanomedicine. We specifically invited Dr. R.
Wang and his colleagues to analyze the trend of cancer
nanomedicine development. In a review, they examined a
dozen cases of particulate nanomedicine for cancer therapeu-
tics or diagnostics applications. At least ten kinds of cancer
nanomedicines have been approved by regulatory bodies to
be commercialized for clinical use, and many therapeutic
or theranostics cancer nanomedicines have been involved
in clinical trials. These encouraging facts show that cancer
nanomedicine is in action, although many technical issues
need to be addressed and it is still a big challenge to meet
safety guidelines for gaining clinical acceptance.
Next, we focus on some technique issues. For example,
surface modification is required to stabilize and function-
alize fluorescent quantum dots for cancer diagnostic and
therapeutic applications. J. Wang et al. summarized some
recent progress and strategies to modify quantum dots, such
as silanization, ligand exchange, and amphiphilic polymer
coatings. These solutions will be applied to optimize the
interface chemistry of quantum dots for potential biological
applications of bioimaging and drug delivery.
In a research article, J. Emami et al. demonstrated the
fabrication of paclitaxel-loaded cholesterol nanostructured
lipid carriers and characterization by measuring the size,
zeta potential, entrapment efficiency, drug loading capacity,
and drug release profiles of the carriers. The results indicate
that the size of carriers is associated with oleic acid content
and surfactant percent, and the ratio of drug payload to
lipidweight significantly affects the entrapment efficiency and
drug release from carriers.
In another research article, S. H. H. Ali et al. synthesized
hippuric acid nanocomposite by intercalating hippuric acid
into zinc-layered hydroxide. Compared to cytarabine alone,
coupling cytarabine with hippuric acid nanocomposite has
higher therapeutic efficacy against human promyelocytic
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leukemia cells. In addition, hippuric acid nanocomposite
demonstrated the capability against bacteria, such as Pseu-
domonas aeruginosa and methicillin-resistant Staphylococcus
aureus.
Recently, gold nanorods have become a rising star in
cancer medicine, because under near-infrared light, the
geometry-related photothermal effect enables gold nanorods
to provide optical coherence tomography contrast for non-
invasive cancer imaging and to ablate targeting cancer cells.
In a research article, Y. Hong et al. systematically investi-
gated how gold nanorod concentration and irradiation laser
power affect the photothermal transduction efficiency of
gold nanorod suspension. The therapeutic efficacy of gold
nanorod-mediated ablation is estimated using MDA-MB-231
breast cancer cell line by live-dead cell staining. They also
developed a versatile system that can simultaneouslymonitor
the temperature variation, uptake of photothermal agents,
and the targeting cell viability.
Toward caner immunotherapy, a gold nanoparticle array-
based sensor on chip fabricated by S. Lee and S. H.
Kang can accurately detect immunomolecules by measur-
ing the fluorescence signal from the interaction between
the gold nanoparticle-captured biotin-labeled antibody and
a streptavidin-labeled dye. The developed single-molecule
sandwich immunoassay is simple, reliable, and sensitive
(40,000-fold higher than conventional chemiluminescence
immunosensors).
Interestingly, besides particulate cancer nanomedicines,
M. J. Mitchell et al. demonstrated a unique device that
can selectively capture and kill flowing cancer cells using
microtube surfaces with immobilized halloysite nanotubes
and E-selectin functionalized liposomal doxorubicin, with-
out toxic effects on health cells. This nonparticulate cancer
nanomedicine opens a new path to conduct cancer diagnosis
and treatment.
The diverse and vigorous investigations published in
this special issue clearly show that cancer nanomedicine is
revolutionizing the field of medicine for cancers.
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